Ivan Kolev, country manager at Wörwag Pharma Bulgaria, explains how has the affiliate performed over the last years as well as shares an overview about the development of diabetes and its complications, and pain management in the country.
You have had two different stages at Wörwag Pharma; working in Actavis between these two periods. What are the factors that triggered you to come back in 2013 from a global player with a leading position in Bulgaria to a mid-cap and family-owned company like Wörwag Pharma?
"Our business in Bulgaria is quite well defined in three main pillars: diabetic and its complications, cardiovascular, and integral pain management."
